COVID-19 in a bone marrow transplant patient

Authors

  • Ayman A. Alharbi Department of Medicine, Qassim university College of Medicine, Qassim, Buraydah, KSA

DOI:

https://doi.org/10.18203/2349-3933.ijam20210605

Keywords:

Coronavirus, Mechanical ventilation, COVID-19

Abstract

Coronavirus disease 2019 (COVID-19) has become a new pandemic with over 190000 cases and 7800 death reported world-wide as of 18 March 2020. Due to its high infectivity and pathogenicity, most people are vulnerable to this virus, especially those with comorbidities. According to a previous study, patients with pre-existing conditions are more likely to require mechanical ventilation, which may lead to a higher risk of death. Post-transplant patients are usually under immunosuppressive therapy; this immune deficiency status may result in opportunistic infections. For now the experience in the management of COVID-19 in the post-transplant population is limited. Here we report COVID-19 case who just underwent transplantation and did not show any disease activity, despite of his suppressed immune status.

References

Kanellopoulos A, Ahmed MZ, Kishore B, Lovell R, Horgan C, Paneesha S, et al. COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience. British J Haematol. 2020;190(2):e67-70.

Zamperlini-Netto G, Fernandes JF, Garcia JL, Ribeiro AA, Camargo LF, de Moraes Terra C, et al. COVID-19 after hematopoietic stem cell transplantation: report of two children. Bone Marrow Transplantation. 2020:1-3.

Downloads

Published

2021-02-23

Issue

Section

Case Reports